CROS NT Appoints Corporate Development Director to Manage Strategic Growth

Giorgio Jones CROS NT24 June 2016 (Maidenhead, UK) – CROS NT announced it appointed Giorgio Jones to the position of Corporate Development Director to support the company’s expansion and development at a global level. Jones’ appointment comes at a time of continued growth for the company, both in terms of geographic reach and service portfolio that now includes clinical development and regulatory services.

Jones brings over 25 years of experience in the pharmaceutical industry to his new role with 20 years spent in the CRO sector covering key roles such as European Financial Controller, Finance and HR Director, and CFO. He is a Chartered Management Accountant and a Chartered Member of the Institute of Personnel and Development.

CROS NT CEO, Andrew MacGarvey, said, “we are pleased to welcome Giorgio to our senior management team as he joins us at a pivotal moment in CROS NT’s development. Over the past two years, CROS NT has made significant progress in expanding both our geographic reach and our portfolio of services. We are now looking to strengthen our leadership team to help us bring our key strategies to fruition. Giorgio has the right blend of experience and skills to lead our development plan.”

Jones added, “I am excited to join an expanding company, one with a reputation for innovation. I look forward to bringing my strengths in business planning and corporate strategy to the team and contributing to CROS NT’s growth”.

#   #   #